Lord, Abbett & Co
BSX icon

Lord, Abbett & Co’s Boston Scientific BSX Stock Holding History

Lord, Abbett & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,122,824
Closed -$110M – 555
2025
Q3 		$110M Sell
1,122,824
-211,945
-16% -$21.9M 0.33% 86
2025
Q2 		$143M Sell
1,334,769
-228,949
-15% -$23.2M 0.46% 61
2025
Q1 		$158M Buy
1,563,718
+691,454
+79% +$69.6M 0.56% 44
2024
Q4 		$77.9M Sell
872,264
-68,850
-7% -$6.06M 0.25% 110
2024
Q3 		$78.9M Sell
941,114
-83,474
-8% -$6.58M 0.25% 121
2024
Q2 		$78.9M Buy
1,024,588
+1,020,936
+27,956% +$74.7M 0.26% 107
2024
Q1 		$250K Sell
3,652
-82,513
-96% -$5.31M ﹤0.01% 533
2023
Q4 		$4.98M Sell
86,165
-34,574
-29% -$1.85M 0.02% 460
2023
Q3 		$6.38M Sell
120,739
-78,952
-40% -$4.14M 0.02% 434
2023
Q2 		$10.8M Buy
+199,691
New +$10.4M 0.04% 411
2021
Q1 		– Sell
-22,862
Closed -$822K – 644
2020
Q4 		$822K Sell
22,862
-16,539
-42% -$596K ﹤0.01% 645
2020
Q3 		$1.51M Sell
39,401
-3,248
-8% -$125K ﹤0.01% 608
2020
Q2 		$1.5M Sell
42,649
-3,621
-8% -$130K 0.01% 620
2020
Q1 		$1.51M Buy
+46,270
New +$1.81M 0.01% 602
2019
Q2 		– Sell
-167,799
Closed -$6.44M – 759
2019
Q1 		$6.44M Sell
167,799
-710,908
-81% -$27.2M 0.02% 625
2018
Q4 		$31.1M Sell
878,707
-533,169
-38% -$19.3M 0.11% 278
2018
Q3 		$54.4M Sell
1,411,876
-607,419
-30% -$21.2M 0.15% 227
2018
Q2 		$66M Buy
+2,019,295
New +$60.9M 0.19% 168
2018
Q1 		– Sell
-550,228
Closed -$13.6M – 832
2017
Q4 		$13.6M Sell
550,228
-1,115,968
-67% -$30.8M 0.04% 568
2017
Q3 		$48.6M Buy
1,666,196
+206,606
+14% +$5.71M 0.14% 223
2017
Q2 		$40.5M Buy
+1,459,590
New +$38.7M 0.12% 266
2016
Q4 		– Sell
-1,190,686
Closed -$28.3M – 872
2016
Q3 		$28.3M Sell
1,190,686
-53,827
-4% -$1.28M 0.09% 367
2016
Q2 		$29.1M Buy
+1,244,513
New +$26.9M 0.09% 340

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Lord, Abbett & Co's BSX Position: Q4 2025 in Review

Lord, Abbett & Co sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 1,122,824 shares — an estimated $110M sold.

Lord, Abbett & Co first reported a position in BSX in Q2 2016 and held it in 23 quarters. The position peaked at $158M in Q1 2025. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Lord, Abbett & Co reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • Lord, Abbett & Co sold 1,122,824 Boston Scientific shares in Q4 2025, an estimated $110M.
  • Lord, Abbett & Co first reported a position in Boston Scientific in Q2 2016 and held it in 23 quarters.
  • Lord, Abbett & Co's Boston Scientific position peaked at $158M in Q1 2025.
  • 1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Lord, Abbett & Co's 13F filing for Q4 2025, filed 13 Feb 2026.